Barsian Darou participation in Hemovigilance and Patient blood Management educational program
Event date: 9th May 2018
Location: Shahid Doctor Lavasani Hospital, Tehran, Iran
Barsian Darou was honored to be a part of executive and scientific team of “Hemovigilance and Patient blood Management” educational program that had been hold on 9th May, 2018 at Shahid Doctor Lavasani Hospital, Tehran, Iran.
Barsian Darou had proudly supported the lecture of Professor Stephan von Haehling from Germany titled “Management of Iron deficiency anemia in cardiac disease”, that took place in Shahid Doctor Lavasani Hospital conference hall, during this scientific event. (9th May 2018).
Event Summary:
“Hemovigilance and Patient blood Management” educational programs are conducted as a joined event by High Institute for Education and Research in Transfusion Medicine and Iranian Society of Blood Transfusion, to enable all the hospital across the country to reduce both anemia and RBC transfusions focusing on both the methodology of how and of what to implement.
Hemovigilance is responsible for successes in transfusion medicine by quantifying errors and adverse events. Hemovigilance also emphasizes the risks of unnecessary transfusions and stimulates the development of evidence‐based guidelines and triggers. Hemovigilance aims at continuous quality improvement and patient safety. Patient blood management promotes improvement of practices to prevent undesirable outcomes. Adoption of both programs is encouraged by demonstration of reduction in both, risks and costs. Measures of success have been the percentage reduction in transfusions and lowering of costs (easy to measure), and not the more desirable increases in appropriate transfusions (difficult to measure).
More than 30% of the world’s population are anemic with serious economic consequences including reduced work capacity and other obstacles to national welfare and development. Red blood cell transfusion is the mainstay to correct anemia, but it is also 1 of the top 5 overused procedures. Patient blood management (PBM) is a proactive, patient-centered, and multidisciplinary approach to manage anemia, optimize hemostasis, minimize iatrogenic blood loss, and harness tolerance to anemia. Although the World Health Organization has endorsed PBM in 2010, many hospitals still seek guidance with the implementation of PBM in clinical routine.
Main topics that were discussed during this event:
- Patient Blood Management planning for implementation
- Indications of red cell transfusion
- Acute transfusion reactions
- Platelet refractoriness management
- Management of Iron deficiency anemia in cardiac disease
- Delay transfusion reaction
Organizing team of this event:
- High Institute for Education and Research in Transfusion Medicine
- Iranian Society of Blood Transfusion
- Research and education department of Shahid Doctor Lavasani Hospital
- Barsian Darou
High Institute for Education and Research in Transfusion Medicine
High Institute for Education and Research in Transfusion Medicine, as an academic institution has the regional and international role to acquire the competencies needed in transfusion medicine to provide services to national and regional state.
Main activities of this institution are: production of knowledge in the field of transfusion medicine and science and the quality of educational services provided by the competent authorities in the region, science and research contribution to the best position in the production and publication of scientific articles in prestigious journals in the world and meeting the needs of the public offering applied research, access to the necessary technology and innovation to produce products and components important determinant for blood transfusion services, present useful methods in providing new and comprehensive plans to enhance the blood transfusion service, provide a platform for all researchers interested in the use of existing facilities and the use of personnel to motivate and empower themselves, education of human resources in the field of transfusion medicine and related sciences in order to train faculty professionals and researcher for needs of High Institute in Transfusion medicine, and other centers of learning and research.
Introducing Professor Stephan von Haehling
Stephan von Haehling is a consultant cardiologist and Associate Professor of Medicine at the Department of Cardiology and Pneumology at the University Medical Center Göttingen, Germany. He obtained his MD at the Institute of Immunology at Charité Medical School, Berlin, Germany. His PhD was awarded by Imperial College, London, UK after he completed studies into inflammatory mechanisms of heart failure at the National Heart and Lung Institute in London. Dr. von Haehling has authored more than 300 original research papers, review articles, and editorials and serves on several editorial boards, including Journal of Cachexia, Sarcopenia and Muscle, ESC Heart Failure, Clinical Science, Expert Opinion on Investigational Drugs and Archives of Medical Science. Dr von Haehling is Fellow of the European Society of Cardiology. His research interests include the pathophysiology of heart failure, muscle wasting, biomarkers, and novel treatments.
(For more info on Hemovigilance and Patient blood Management” educational programs, go to the link:http://www.tmi.ac.ir/DesktopModules/News/NewsView.aspx?TabID=1&Site=TMI&Lang=fa-IR&ItemID=1946&mid=14901&wVersion=Staging)
